|
FY2026
12 months to Jun 28, 2026
|
FY2025
12 months to Jun 29, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jul 2, 2023
|
FY2022
12 months to Jul 3, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues (excludes depreciation and amortization) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Marketing and sales | |||||
| Technology and development | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Goodwill and intangible impairment | |||||
| Goodwill impairment | |||||
| Intangible impairment | |||||
| Total goodwill and intangible impairment | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest expense, net | |||||
| Interest income | |||||
| Interest expense | |||||
| Total interest expense, net | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net loss | |||||
| Other comprehensive income (loss) - currency translation | |||||
| Comprehensive loss | |||||
| Basic net loss per common share (in dollars per share) | |||||
| Diluted net loss per common share (in dollars per share) | |||||
| Weighted average shares used in the calculation of net loss per common share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...